TY - JOUR
T1 - Corrigendum to “Mitochondria-targeted MXene@MnO2-TPP nanoheterostructures for synergistic enhancement of sonodynamic therapy and immunotherapy in osteosarcoma” [Bioact. Mat. 54 (2025) 450–465, (S2452199X25003913), (10.1016/j.bioactmat.2025.08.029)]
AU - Zeng, Jin
AU - Yan, Zuyun
AU - Wang, Dong
AU - He, Tao
AU - Tong, Zhaochen
AU - Miao, Jinglei
AU - Li, Jinsong
AU - Tan, Wei
AU - Chen, Shijie
AU - Deng, Youwen
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2026/2
Y1 - 2026/2
N2 - The authors regret after reviewing their publication “Mitochondria-targeted MXene@MnO2-TPP nanoheterostructures for synergistic enhancement of sonodynamic therapy and immunotherapy in osteosarcoma”, they found that there were mistakes for the calcein-AM/PI co-staining of NP-MXene group (Fig. 4B) and ROS staining of NP-MnO2 group (Supplementary Fig. S5A), which were due to the incorrect compilation. The correct Fig. 4B and Supplementary Fig. S5 was presented below. All authors consent on this necessary correction and all the results and conclusions of the article remain unchanged. No additional text corrections are needed in the article. We sincerely apologize for the mistakes. The authors would like to apologize for any inconvenience caused. Correct Fig. 4B.[Figure presented] Correct Supplementary Fig. S5[Figure presented] CRediT authorship contribution statement Jin Zeng: Data curation, Formal analysis, Writing – original draft. Zuyun Yan: Conceptualization, Resources. Dong Wang: Formal analysis, Validation. Tao He: Methodology, Validation. Zhaochen Tong: Formal analysis, Validation. Jinglei Miao: Formal analysis, Resources. Jinsong Li: Formal analysis, Resources. Wei Tan: Formal analysis, Resources. Shijie Chen: Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision. Youwen Deng: Project administration, Supervision, Writing – review & editing.
AB - The authors regret after reviewing their publication “Mitochondria-targeted MXene@MnO2-TPP nanoheterostructures for synergistic enhancement of sonodynamic therapy and immunotherapy in osteosarcoma”, they found that there were mistakes for the calcein-AM/PI co-staining of NP-MXene group (Fig. 4B) and ROS staining of NP-MnO2 group (Supplementary Fig. S5A), which were due to the incorrect compilation. The correct Fig. 4B and Supplementary Fig. S5 was presented below. All authors consent on this necessary correction and all the results and conclusions of the article remain unchanged. No additional text corrections are needed in the article. We sincerely apologize for the mistakes. The authors would like to apologize for any inconvenience caused. Correct Fig. 4B.[Figure presented] Correct Supplementary Fig. S5[Figure presented] CRediT authorship contribution statement Jin Zeng: Data curation, Formal analysis, Writing – original draft. Zuyun Yan: Conceptualization, Resources. Dong Wang: Formal analysis, Validation. Tao He: Methodology, Validation. Zhaochen Tong: Formal analysis, Validation. Jinglei Miao: Formal analysis, Resources. Jinsong Li: Formal analysis, Resources. Wei Tan: Formal analysis, Resources. Shijie Chen: Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision. Youwen Deng: Project administration, Supervision, Writing – review & editing.
UR - https://www.scopus.com/pages/publications/105019332018
U2 - 10.1016/j.bioactmat.2025.09.034
DO - 10.1016/j.bioactmat.2025.09.034
M3 - 评论/辩论
AN - SCOPUS:105019332018
SN - 2452-199X
VL - 56
SP - 232
EP - 233
JO - Bioactive Materials
JF - Bioactive Materials
ER -